128 related articles for article (PubMed ID: 38377652)
1. The value of performance status in predicting venous thromboembolism in lung cancer patients treated with immune checkpoint inhibitors.
Zhang J; Yang L; Tian H; Xu R; Liu D
Eur J Oncol Nurs; 2024 Apr; 69():102527. PubMed ID: 38377652
[TBL] [Abstract][Full Text] [Related]
2. Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study.
Farmakis IT; Barco S; Mavromanoli AC; Konstantinides SV; Valerio L
JACC CardioOncol; 2022 Nov; 4(4):507-518. PubMed ID: 36444229
[TBL] [Abstract][Full Text] [Related]
3. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
4. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolic events in T-cell lymphoma patients: Incidence, risk factors and clinical features.
Lan Y; Guan J; Zhu J; Wang J; Li M; Sun C; Sun F; Huang J; Lu S; Zhang Y
Leuk Res; 2021 Apr; 103():106537. PubMed ID: 33631621
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Symptomatic Deep Venous Thrombosis and Pulmonary Embolism After Anterior Cruciate Ligament Reconstruction.
Gaskill T; Pullen M; Bryant B; Sicignano N; Evans AM; DeMaio M
Am J Sports Med; 2015 Nov; 43(11):2714-9. PubMed ID: 26391861
[TBL] [Abstract][Full Text] [Related]
7. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
[TBL] [Abstract][Full Text] [Related]
9. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
[TBL] [Abstract][Full Text] [Related]
10. Neuromuscular electrical stimulation for the prevention of venous thromboembolism.
Hajibandeh S; Hajibandeh S; Antoniou GA; Scurr JR; Torella F
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011764. PubMed ID: 29161465
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
[TBL] [Abstract][Full Text] [Related]
12. Pentasaccharides for the prevention of venous thromboembolism.
Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of venous thromboembolism after lung surgery in China: a single-centre, prospective cohort study involving patients undergoing lung resections without perioperative venous thromboembolism prophylaxis†.
Song C; Shargall Y; Li H; Tian B; Chen S; Miao J; Fu Y; You B; Hu B
Eur J Cardiothorac Surg; 2019 Mar; 55(3):455-460. PubMed ID: 30289479
[TBL] [Abstract][Full Text] [Related]
14. Comparison among different presentations of venous thromboembolism because of lung cancer.
Guo J; Deng QF; Xiong W; Pudasaini B; Yuan P; Liu JM; Zhou CC
Clin Respir J; 2019 Sep; 13(9):574-582. PubMed ID: 31306554
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact and risk factors of cancer-associated thrombosis events in stage-IV cancer patients treated with immune checkpoint inhibitors.
Kewan T; Ko T; Flores M; Sallam Y; Haddad A; Daw H
Eur J Haematol; 2021 May; 106(5):682-688. PubMed ID: 33565130
[TBL] [Abstract][Full Text] [Related]
16. Perioperative Blood Transfusions Are Associated with a Higher Incidence of Thromboembolic Events After TKA: An Analysis of 333,463 TKAs.
Acuña AJ; Grits D; Samuel LT; Emara AK; Kamath AF
Clin Orthop Relat Res; 2021 Mar; 479(3):589-600. PubMed ID: 33165044
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy.
Secin FP; Jiborn T; Bjartell AS; Fournier G; Salomon L; Abbou CC; Haber GP; Gill IS; Crocitto LE; Nelson RA; Cansino Alcaide JR; Martínez-Piñeiro L; Cohen MS; Tuerk I; Schulman C; Gianduzzo T; Eden C; Baumgartner R; Smith JA; Entezari K; van Velthoven R; Janetschek G; Serio AM; Vickers AJ; Touijer K; Guillonneau B
Eur Urol; 2008 Jan; 53(1):134-45. PubMed ID: 17597288
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients.
He X; Wei SN; Qin WW; Geng N; Li B; Song S; Wang P
Expert Rev Hematol; 2023; 16(12):1135-1142. PubMed ID: 37883026
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for symptomatic venous thromboembolism following cholecystectomy.
Strömberg J; Sadr-Azodi O; Videhult P; Hammarqvist F; Sandblom G
Langenbecks Arch Surg; 2015 May; 400(4):463-9. PubMed ID: 25682056
[TBL] [Abstract][Full Text] [Related]
20. Does tranexamic acid increase venous thromboembolism risk among trauma patients? A prospective multicenter analysis across 17 level I trauma centers.
Knowlton LM; Arnow K; Trickey AW; Sauaia A; Knudson MM
Injury; 2023 Nov; 54(11):111008. PubMed ID: 37669883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
